Mass balance study of [14C]-ABBV-552, a synaptic vesicle glycoprotein 2A positive modulator, in healthy male participants following single oral dose administration
European Journal of Clinical Pharmacology · 2026-08 · 82 (8)
DOI: 10.1007/s00228-026-04078-8 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift European Journal of Clinical Pharmacology, online erschienen am 21.07.2026. Verfasst von Nick Miles und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacology, AbbVie Inc., North Chicago, IL, USA. nick.miles@abbvie.com. Hauptthemen laut MEDLINE: Membrane Glycoproteins, Nerve Tissue Proteins. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: AbbVie.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Pharmacology, AbbVie Inc., North Chicago, IL, USA. nick.miles@abbvie.com.
- Clinical Pharmacology, AbbVie Inc., North Chicago, IL, USA.
- Clinical Development Neuroscience, AbbVie Inc., North Chicago, IL, USA.
- Global Patient Safety, AbbVie Inc., North Chicago, IL, USA.
- Development Biological Sciences, AbbVie Inc., North Chicago, IL, USA.
- Quantitative, Translational ADME Sciences, AbbVie Inc., North Chicago, IL, USA.
Förderung
- AbbVie
Zitieren
APA
Miles, N., McNamee, B., Soleman, S. I., Zadikoff, C., Boiser, J., Laplanche, L., Burton, R., Shebley, M., & Boinpally, R. R. (2026). Mass balance study of [14C]-ABBV-552, a synaptic vesicle glycoprotein 2A positive modulator, in healthy male participants following single oral dose administration. European Journal of Clinical Pharmacology, 82(8). https://doi.org/10.1007/s00228-026-04078-8
Vancouver
Miles N, McNamee B, Soleman SI, Zadikoff C, Boiser J, Laplanche L, et al. Mass balance study of [14C]-ABBV-552, a synaptic vesicle glycoprotein 2A positive modulator, in healthy male participants following single oral dose administration. European Journal of Clinical Pharmacology. 2026;82(8). doi:10.1007/s00228-026-04078-8
BibTeX
@article{Miles2026,
author = {Miles, Nick and McNamee, Brian and Soleman, Sharif I and Zadikoff, Cindy and Boiser, Joey and Laplanche, Loic and Burton, Richard and Shebley, Mohamad and Boinpally, Ramesh R},
title = {Mass balance study of [14C]-ABBV-552, a synaptic vesicle glycoprotein 2A positive modulator, in healthy male participants following single oral dose administration},
journal = {European Journal of Clinical Pharmacology},
year = {2026},
volume = {82},
number = {8},
doi = {10.1007/s00228-026-04078-8}
}
EUVIMED